BioLife Solutions Dirección
Dirección controles de criterios 2/4
El CEO de BioLife Solutions' es Rod de Greef , nombrado en Oct 2023, tiene una permanencia de menos de un año. compensación anual total es $6.39M, compuesta por 3.1% salario y 96.9% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.15% de las acciones de la empresa, por valor de $1.13M. La antigüedad media del equipo directivo y de la junta directiva es de 2.4 años y 15.4 años, respectivamente.
Información clave
Rod de Greef
Chief Executive Officer (CEO)
US$6.4m
Compensación total
| Porcentaje del salario del CEO | 3.1% |
| Permanencia del CEO | less than a year |
| Participación del CEO | 0.1% |
| Permanencia media de la dirección | 2.5yrs |
| Promedio de permanencia en la Junta Directiva | 15.5yrs |
Actualizaciones recientes de la dirección
Recent updates
Does BioLife Solutions (NASDAQ:BLFS) Have A Healthy Balance Sheet?
Mar 12
BioLife Solutions, Inc.'s (NASDAQ:BLFS) Intrinsic Value Is Potentially 64% Above Its Share Price
Feb 19BioLife Solutions, Inc.'s (NASDAQ:BLFS) Share Price Matching Investor Opinion
Dec 19Downgrade: Here's How Analysts See BioLife Solutions, Inc. (NASDAQ:BLFS) Performing In The Near Term
Aug 17Is BioLife Solutions (NASDAQ:BLFS) Weighed On By Its Debt Load?
Aug 11Health Check: How Prudently Does BioLife Solutions (NASDAQ:BLFS) Use Debt?
May 06Should You Think About Buying BioLife Solutions, Inc. (NASDAQ:BLFS) Now?
Feb 22Health Check: How Prudently Does BioLife Solutions (NASDAQ:BLFS) Use Debt?
Jan 10Is There An Opportunity With BioLife Solutions, Inc.'s (NASDAQ:BLFS) 20% Undervaluation?
Dec 10BioLife: What The Future Holds
Oct 19BioLife Solutions COO Roderick de Greef to retire
Oct 03BioLife Solutions (NASDAQ:BLFS) Has Debt But No Earnings; Should You Worry?
Sep 27BioLife Solutions GAAP EPS of -$1.71 misses by $1.50, revenue of $40.5M beats by $1.33M
Aug 09BioLife Solutions: Sell-Side Posture Overly Optimistic, Rate Neutral
Jul 29Is BioLife Solutions (NASDAQ:BLFS) Using Debt Sensibly?
Jun 15BioLife: Can This Company Successfully Turn Around?
Apr 18Temporary Setbacks At BioLife
Mar 02Is BioLife Solutions (NASDAQ:BLFS) A Risky Investment?
Jan 11BioLife: Poised For Growth
Dec 22Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | US$6m | US$199k | -US$66m |
| Sep 30 2023 | n/a | n/a | -US$102m |
| Jun 30 2023 | n/a | n/a | -US$83m |
| Mar 31 2023 | n/a | n/a | -US$146m |
| Dec 31 2022 | US$2m | US$450k | -US$140m |
| Sep 30 2022 | n/a | n/a | -US$106m |
| Jun 30 2022 | n/a | n/a | -US$96m |
| Mar 31 2022 | n/a | n/a | -US$15m |
| Dec 31 2021 | US$1m | US$412k | -US$9m |
| Sep 30 2021 | n/a | n/a | US$5m |
| Jun 30 2021 | n/a | n/a | US$4m |
| Mar 31 2021 | n/a | n/a | -US$20m |
| Dec 31 2020 | US$3m | US$391k | US$2m |
| Sep 30 2020 | n/a | n/a | US$7m |
| Jun 30 2020 | n/a | n/a | US$16m |
| Mar 31 2020 | n/a | n/a | US$39m |
| Dec 31 2019 | US$1m | US$403k | -US$2m |
| Sep 30 2019 | n/a | n/a | -US$32m |
| Jun 30 2019 | n/a | n/a | -US$39m |
| Mar 31 2019 | n/a | n/a | -US$44m |
| Dec 31 2018 | US$490k | US$350k | -US$25m |
| Sep 30 2018 | n/a | n/a | US$1m |
| Jun 30 2018 | n/a | n/a | -US$146k |
| Mar 31 2018 | n/a | n/a | -US$2m |
| Dec 31 2017 | US$520k | US$300k | -US$3m |
Compensación vs. Mercado: La compensación total de Rod($USD6.39M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD3.44M).
Compensación vs. Ingresos: La compensación de Rod ha aumentado mientras la empresa no es rentable.
CEO
Rod de Greef (63 yo)
less than a year
Permanencia
US$6,387,586
Compensación
Mr. Roderick de Greef, also known as Rod, serves as Director of BioLife Solutions, Inc. since January 03, 2023 and serves as its Chief Executive Officer & Chairman since October 20, 2023. He had been Presi...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Chairman | less than a year | US$6.39m | 0.15% $ 1.2m | |
| Chief Financial Officer | 2.5yrs | US$1.70m | 0.28% $ 2.3m | |
| Chief Quality & Operations Officer | less than a year | US$1.12m | 0.35% $ 2.9m | |
| Chairman of Scientific Advisory Board | 4.4yrs | US$1.35m | 0.70% $ 5.8m | |
| Chief Marketing Officer | 9.3yrs | US$734.45k | 0.29% $ 2.3m | |
| Chief Human Resources Officer | 3.3yrs | sin datos | 0.14% $ 1.2m | |
| Chief Revenue Officer | less than a year | sin datos | 0.26% $ 2.1m |
2.5yrs
Permanencia media
51yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de BLFS se considera experimentado (2.4 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Chairman | 1.3yrs | US$6.39m | 0.15% $ 1.2m | |
| Chairman of Scientific Advisory Board | no data | US$1.35m | 0.70% $ 5.8m | |
| Member of Scientific Advisory Board | 17.6yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | 16.7yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | 17.6yrs | sin datos | sin datos | |
| Independent Director | 10.5yrs | US$253.75k | 0.097% $ 792.5k | |
| Member of the Scientific Advisory Board | no data | US$284.00k | sin datos | |
| Member of Scientific Advisory Board | 16.7yrs | sin datos | sin datos | |
| Member of the Scientific Advisory Board | no data | sin datos | sin datos | |
| Lead Director | 3.1yrs | US$269.17k | 0.065% $ 530.9k | |
| Independent Director | 2.6yrs | US$250.00k | 0.091% $ 741.2k | |
| Member of Scientific Advisory Board | 15.5yrs | sin datos | sin datos |
15.5yrs
Permanencia media
57.5yo
Promedio de edad
Junta con experiencia: Los miembros de la junta directiva de BLFS son experimentados ( 15.4 años antigüedad media).